Trexquant Investment LP Invests $166,000 in GoHealth, Inc. $GOCO

Trexquant Investment LP purchased a new position in shares of GoHealth, Inc. (NASDAQ:GOCO) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 13,567 shares of the company’s stock, valued at approximately $166,000. Trexquant Investment LP owned approximately 0.06% of GoHealth at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the stock. Point72 Asset Management L.P. purchased a new stake in GoHealth in the fourth quarter valued at about $675,000. Citadel Advisors LLC acquired a new stake in GoHealth during the fourth quarter worth about $664,000. Northern Trust Corp grew its holdings in GoHealth by 11.6% during the fourth quarter. Northern Trust Corp now owns 48,427 shares of the company’s stock worth $648,000 after acquiring an additional 5,040 shares during the period. Russell Investments Group Ltd. grew its holdings in GoHealth by 77.3% in the first quarter. Russell Investments Group Ltd. now owns 37,366 shares of the company’s stock valued at $458,000 after purchasing an additional 16,290 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in GoHealth in the first quarter valued at approximately $212,000. 24.21% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

GOCO has been the topic of several research reports. Wall Street Zen downgraded GoHealth from a “hold” rating to a “sell” rating in a research report on Friday, July 18th. Noble Financial restated an “outperform” rating on shares of GoHealth in a research report on Friday, August 8th. Finally, Royal Bank Of Canada reduced their target price on GoHealth from $18.00 to $12.00 and set a “sector perform” rating on the stock in a research report on Thursday, August 28th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, GoHealth currently has a consensus rating of “Moderate Buy” and a consensus target price of $12.00.

GoHealth Stock Performance

NASDAQ GOCO opened at $4.75 on Thursday. The business has a 50 day moving average price of $5.65 and a 200 day moving average price of $8.26. The company has a market capitalization of $135.90 million, a P/E ratio of -1.32 and a beta of 1.61. The company has a debt-to-equity ratio of 2.64, a current ratio of 1.56 and a quick ratio of 1.56. GoHealth, Inc. has a 1-year low of $4.64 and a 1-year high of $21.00.

GoHealth (NASDAQ:GOCO) last posted its quarterly earnings data on Thursday, August 7th. The company reported ($1.23) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.60) by $1.37. GoHealth had a negative return on equity of 8.74% and a negative net margin of 3.21%.The business had revenue of $94.05 million for the quarter, compared to analysts’ expectations of $119.76 million. Sell-side analysts expect that GoHealth, Inc. will post -5.5 EPS for the current fiscal year.

About GoHealth

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.